1. Stock and Flow of Peritoneal Dialysis Patients Australia 2001 - 2005
Number of Patients
New Patients
Transplants
Perm. Transfer
Deaths
No. Dialysing
1796
Patients

2. Stock and Flow of Peritoneal Dialysis Patients New Zealand 2001 - 2005
Number of Patients
New Patients
Transplants
Perm. Transfer
Deaths
No. Dialysing
720
Patients

3. Age of New PD Patients 2005 Australia No.
Pats

4. Age of Dialysing PD Patients 31-Dec-2005
Australia
No.
Pats

5. PD Patients (%) of all Prevalent Dialysis
Australia 31-Dec-2005

6. Number (Per Million) Prevalent PD Patients
Australia
% Diab 24% % % % %

7. Number of Prevalent APD/CAPD Patients
Australia
% APD 28% % % % %

8. Number (Per Million) Prevalent APD Patients
Australia
% Diab 20% % % % %

9. PD Patients (%) of all Prevalent Dialysis
New Zealand 31-Dec-2005

10. Number (Per Million) Prevalent PD Patients
New Zealand
% Diab 39% % % % %

11. Number of Prevalent APD/CAPD Patients
New Zealand
% APD 16% % % % %

12. Number (Per Million) Prevalent APD Patients
New Zealand
% Diab 29% % % % %

13. Age of New PD Patients 2005 New Zealand No.
Pats

14. Age of Dialysing PD Patients
New Zealand 31-Dec-2005
No.
Pats

15. Patient Survival - PD at 90 days Censored for Transplant
0.00
0.25
0.50
0.75
1.00
Probability of survival 1 2 3 4 5
Years
(1650)
(1705)
(1844)
(1861)
Patient Survival - PD at 90 days
Censored for Transplant
Australia

16. Patient Survival - PD at 90 days Censored for Transplant
New Zealand
1.00
0.75
Probability of survival
0.50
0.25
(500)
(545)
(664)
(647)
0.00 1 2 3 4 5
Years

17. Patient Survival - PD at 90 days Censored for Transplant
0.00
0.25
0.50
0.75
1.00
Probability of survival 1 2 3 4 5
Years
Non-diabetic (5272)
Diabetic (1788)
Patient Survival - PD at 90 days
Censored for Transplant
Australia

18. Patient Survival - PD at 90 days Censored for Transplant
0.00
0.25
0.50
0.75
1.00
Probability of survival 1 2 3 4 5
Years
Non-diabetic (1379)
Diabetic (1027)
Patient Survival - PD at 90 days
Censored for Transplant
New Zealand

19. Patient Survival - PD at 90 days Censored for Transplant
0.00
0.25
0.50
0.75
1.00
Probability of survival 1 2 3 4 5
Years
<40 (1062)
40-59 (2110)
60-74 (2970)
>=75 (918)
Patient Survival - PD at 90 days
Censored for Transplant
Australia

20. Patient Survival - PD at 90 days Censored for Transplant
0.00
0.25
0.50
0.75
1.00
Probability of survival 1 2 3 4 5
Years
<40 (367)
40-59 (957)
60-74 (909)
>=75 (173)
Patient Survival - PD at 90 days
Censored for Transplant
New Zealand

21. Adjusted Patient Survival - PD at 90 days Censored for Transplant
Australia
0.00
0.25
0.50
0.75
1.00
Probability of survival 1 2 3 4 5
Years
(1650)
(1705)
(1844)
(1861)

22. Adjusted Patient Survival - PD at 90 days Censored for Transplant
New Zealand
1.00
0.75
Probability of survival
0.50
0.25
(500)
(545)
(664)
(647)
0.00 1 2 3 4 5
Years

23. First PD Treatment to First Peritonitis Related to Age at Entry 2001 - 2005
% Survival
Australia
Age Group

24. First PD Treatment to First Peritonitis Related to Age at Entry 2001 - 2005
% Survival
New Zealand
Age Group

25. First PD Treatment to First Peritonitis Related to Race
Australia
Caucasoid
35-54 yrs
55-64 yrs
35-54 yrs
Aboriginal/Torres St
Maori/Pacific People
55-64 yrs

26. First PD Treatment to First Peritonitis Related to Race
Australia
Caucasoid
55-64 yrs
35-54 yrs
55-64 yrs
Aboriginal/Torres St
Maori/Pacific People
35-54 yrs

27. First PD Treatment to First Peritonitis Related to Race
New Zealand
Caucasoid
35-54 yrs
55-64 yrs
35-54 yrs
55-64 yrs
Maori/Pacific
People

28. First PD Treatment to First Peritonitis Related to Race
New Zealand
Caucasoid
35-54 yrs
55-64 yrs
35-54 yrs
55-64 yrs
Maori/Pacific
People

29. Number of PD Episodes Number of PD episodes per person Proportion .6.4
Proportion .2 5 10
Number of PD episodes per person

31. Vancomycin by Organism
Gram positives only
Culture negative
Coag neg Staph
MRSA
Staph aureus
non MRSA
Other Gram Pos .2 .4 .6 .8
Proportion
Vancomycin in antibiotic regimen
First
Second

32. Initial Antibiotic Regimen.8 .6
Proportion of initial antibiotic regimens .4 .2 NT
NSW/ACT
Vic
Qld SA WA
Tas
Initial antibiotic regimen
Vancomycin
Aminoglycoside